NCT03630250View on ClinicalTrials.gov

Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Meningitis, BacterialNeisseria Infection
Interventions
BIOLOGICAL

N. lactamica

Genetically modified N. lactamica

Trial Locations (1)

Unknown

NIHR Southampton Clinical Research Facility, Southampton

All Listed Sponsors
collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

lead

University of Southampton

OTHER

NCT03630250 - Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA) | Biotech Hunter | Biotech Hunter